|
|
|
| Webinar: Demystifying Large Scale Continuous Chromatography for Small Molecules | This webinar provides an introduction to developing continuous chromatography using Simulated Moving Bed (SMB) Technology for small molecule applications. Key benefits include rapid development, easy scale-up, cGMP compliance, cost-effectiveness, and sustainability. Attendees will learn the basics of SMB, its advantages over other technologies, and its sustainability benefits. Click here to learn more. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Persephoni BioPartners CEO Hilary Shultz has created a business model that may propel “externalization” to an ultimate implementation: The formation of a biotech by outsourcing the entire organization, which then outsources to advance an asset. Shultz describes Persephoni as a “venture studio.” Chief Editor Louis Garguilo investigates further ... |
|
|
Are We Witnessing A New 'Age Of The CDMO'? | By Paul J. Cummings, PJC Pharma Consulting Ltd. | Over the past few years, the pharma/biotech industry has seen a significant shift from internal to external manufacturing. This article examines the driving factors and the author's perspective for what to expect in 2025 and beyond. |
|
|
|
Fluid Bed And Melt Granulation In Pharmaceutical Manufacturing | Article | By Brian C. Anderson and Daniel Mateo-Ortiz, AbbVie | Fluid bed and melt granulation represent an opportunity for drug developers to achieve appreciable efficiency gains in their processes, as well as measurable improvements in their final drug products. |
|
|
|
|
|
|
|
Expanding The OSD Toolbox | Webinar | Alcami | This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations. |
|
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|